Survival and Lates Effects of JPLT (Japanese Study Group for Rediatric Liver Tumor)-2 Risk-Stratified Study for Hepatoblastoma

被引:0
|
作者
Hiyama, E. [1 ]
Hishiki, T. [2 ]
Ida, K. [2 ]
Watanabe, K. [2 ]
Tanaka, Y. [2 ]
Aoki, Y. [2 ]
Iehara, T. [2 ]
Kazama, T. [2 ]
Kihira, K. [2 ]
Taguchi, T. [2 ]
Fujimura, J. [2 ]
Hoshino, K. [2 ]
Honda, S. [2 ]
Matsumoto, K. [2 ]
Mori, M. [2 ]
Yano, M. [2 ]
机构
[1] Hiroshima Univ Hosp, Peditr Surg, Hiroshima, Japan
[2] Japanese Children Canc Grp, Liver Tumor Comm, Tokyo, Japan
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
O-126
引用
收藏
页码:S71 / S71
页数:1
相关论文
共 50 条
  • [21] Feasibility of dose-dense cisplatin-based chemotherapy in Japanese children with high-risk hepatoblastoma: Analysis of the JPLT3-H pilot study
    Watanabe, Kenichiro
    Mori, Makiko
    Hishiki, Tomoro
    Yokoi, Akiko
    Ida, Kohmei
    Yano, Michihiro
    Fujimura, Junya
    Nogami, Yuki
    Iehara, Tomoko
    Hoshino, Ken
    Inoue, Takeshi
    Tanaka, Yukichi
    Miyazaki, Osamu
    Takimoto, Tetsuya
    Yoshimura, Kenichi
    Hiyama, Eiso
    PEDIATRIC BLOOD & CANCER, 2022, 69 (02)
  • [22] Erratum to: Risk-stratified survival rates and predictors of biochemical recurrence after radical prostatectomy in a Nara, Japan, cohort study
    Nobumichi Tanaka
    Kiyohide Fujimoto
    Akihide Hirayama
    Kazumasa Torimoto
    Eijiro Okajima
    Masahiro Tanaka
    Makito Miyake
    Keiji Shimada
    Noboru Konishi
    Yoshihiko Hirao
    International Journal of Clinical Oncology, 2014, 19 : 208 - 208
  • [23] Exploring women's acceptability of risk-stratified breast cancer screening and primary prevention: a European focus group study
    Rainey, Linda
    Jervaeus, Anna
    Donnelly, Louise
    Evans, Gareth
    Hammarstrom, Mattias
    Hall, Per
    Wengstrom, Yvonne
    Broeders, Mireille
    van der Waal, Danielle
    INTERNATIONAL JOURNAL OF BEHAVIORAL MEDICINE, 2021, 28 (SUPPL 1) : S43 - S43
  • [24] Feasibility of Dose-Dense Cisplatin-Based Chemotherapy in Japanese Children With High-Risk Hepatoblastoma: A Result from JPLT3-H Study
    Watanabe, Kenichiro
    Mori, Makiko
    Hishki, Tomoro
    Ida, Kohmei
    Yokoi, Akiko
    Yano, Michihiro
    Fujimura, Junya
    Nogami, Yuki
    Iehara, Tomoko
    Hoshino, Ken
    Tanaka, Yukichi
    Miyazaki, Osamu
    Takimoto, Tetsuya
    Yoshimura, Kenichi
    Hiyama, Eiso
    PEDIATRIC BLOOD & CANCER, 2019, 66 : S66 - S67
  • [25] Feasibility of Dose-Dense Cisplatin-based Chemotherapy in Japanese Children with High-Risk Hepatoblastoma: A Result from JPLT3-H Study
    Watanabe, K.
    Mori, M.
    Hishiki, T.
    Ida, K.
    Yokoi, A.
    Yano, M.
    Fujimura, J.
    Nogami, Y.
    Iehara, T.
    Hoshino, K.
    Tanaka, Y.
    Miyazaki, O.
    Yoshimura, K.
    Takimoto, T.
    Hiyama, E.
    PEDIATRIC BLOOD & CANCER, 2019, 66 : S66 - S67
  • [26] Outcome and Late Complications of Hepatoblastomas Treated Using the Japanese Study Group for Pediatric Liver Tumor 2 Protocol
    Hiyama, Eiso
    Hishiki, Tomoro
    Watanabe, Kenichiro
    Ida, Kohmei
    Ueda, Yuka
    Kurihara, Sho
    Yano, Michihiro
    Hoshino, Ken
    Yokoi, Akiko
    Takama, Yuichi
    Nogami, Yuki
    Taguchi, Tomoaki
    Mori, Makiko
    Kihira, Kentaro
    Miyazaki, Osamu
    Fuji, Hiroshi
    Honda, Shohei
    Iehara, Tomoko
    Kazama, Takuro
    Fujimura, Junya
    Tanaka, Yukichi
    Inoue, Takeshi
    Tajiri, Tatsuro
    Kondo, Satoshi
    Oue, Takaharu
    Yoshimura, Kenichi
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (22) : 2488 - +
  • [27] Risk-Stratified Therapy and the Intensive Use of Cytarabine Improves the Outcome in Childhood Acute Myeloid Leukemia: The AML99 Trial From the Japanese Childhood AML Cooperative Study Group
    Tsukimoto, Ichiro
    Tawa, Akio
    Horibe, Keizo
    Tabuchi, Ken
    Kigasawa, Hisato
    Tsuchida, Masahiro
    Yabe, Hiromasa
    Nakayama, Hideki
    Kudo, Kazuko
    Kobayashi, Ryoji
    Hamamoto, Kazuko
    Imaizumi, Masue
    Morimoto, Akira
    Tsuchiya, Shigeru
    Hanada, Ryoji
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (24) : 4007 - 4013
  • [28] Conventional Resection Versus Primary OLT and Intensified Chemotherapy in PRETEXT IV Hepatoblastoma Results of the GPOH Liver Tumor Study Group
    Haeberle, B.
    Becker, K.
    Schmid, I.
    Von Schweinitz, D.
    PEDIATRIC BLOOD & CANCER, 2020, 67 : S104 - S105
  • [29] Risk-stratified survival rates and predictors of biochemical recurrence after radical prostatectomy in a Nara, Japan, cohort study (vol 16, pg 553, 2011)
    Tanaka, Nobumichi
    Fujimoto, Kiyohide
    Hirayama, Akihide
    Torimoto, Kazumasa
    Okajima, Eijiro
    Tanaka, Masahiro
    Miyake, Makito
    Shimada, Keiji
    Konishi, Noboru
    Hirao, Yoshihiko
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2014, 19 (01) : 208 - 208
  • [30] Predictive value of the pretreatment extent of disease system in hepatoblastoma: Results from the International Society of Pediatric Oncology Liver Tumor Study Group SIOPEL-1 Study
    Aronson, DC
    Schnater, JM
    Staalman, CR
    Weverling, GJ
    Plaschkes, J
    Perilongo, G
    Brown, J
    Phillips, A
    Otte, JB
    Czauderna, P
    MacKinlay, G
    Vos, A
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (06) : 1245 - 1252